GlucoTrack, Inc.
GCTK
$7.42
-$0.24-3.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 129.29% | 110.33% | 48.67% | 23.14% | 3.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 72.09% | 104.77% | 119.45% | 158.24% | 89.73% |
| Operating Income | -72.09% | -104.77% | -119.45% | -158.24% | -89.73% |
| Income Before Tax | -203.31% | -218.40% | -149.75% | -157.67% | -88.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -203.31% | -218.40% | -149.75% | -157.67% | -88.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -203.31% | -218.40% | -149.75% | -157.67% | -88.81% |
| EBIT | -72.09% | -104.77% | -119.45% | -158.24% | -89.73% |
| EBITDA | -72.09% | -104.94% | -119.92% | -158.46% | -89.94% |
| EPS Basic | -- | -- | -- | -- | -- |
| Normalized Basic EPS | -- | -- | -- | -- | -- |
| EPS Diluted | -- | -- | -- | -- | -- |
| Normalized Diluted EPS | -- | -- | -- | -- | -- |
| Average Basic Shares Outstanding | -- | -- | -- | -- | -- |
| Average Diluted Shares Outstanding | -- | -- | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |